David J. Lederer

1994–2024 年に発表

119
論文数
28,076
被引用数
65
h 指数
114
i10 指数

被引用数

David J. Lederer の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 2 件2002 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 4 件2005 年: 被引用 6 件2006 年: 被引用 2 件2007 年: 被引用 11 件2008 年: 被引用 23 件2009 年: 被引用 15 件2010 年: 被引用 18 件2011 年: 被引用 28 件2012 年: 被引用 32 件2013 年: 被引用 70 件2014 年: 被引用 96 件2015 年: 被引用 139 件2016 年: 被引用 181 件2017 年: 被引用 251 件2018 年: 被引用 255 件2019 年: 被引用 1,096 件2020 年: 被引用 1,497 件2021 年: 被引用 1,644 件2022 年: 被引用 1,301 件2023 年: 被引用 956 件2024 年: 被引用 1,436 件2025 年: 被引用 587 件2026 年: 被引用 20 件1994 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません1998〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,812 件、この内訳の 23.8%中国: 引用元論文 1,093 件、この内訳の 9.2%イギリス: 引用元論文 942 件、この内訳の 8%イタリア: 引用元論文 655 件、この内訳の 5.5%ドイツ: 引用元論文 628 件、この内訳の 5.3%カナダ: 引用元論文 606 件、この内訳の 5.1%日本: 引用元論文 543 件、この内訳の 4.6%フランス: 引用元論文 468 件、この内訳の 4%オーストラリア: 引用元論文 445 件、この内訳の 3.8%オランダ: 引用元論文 340 件、この内訳の 2.9%スペイン: 引用元論文 318 件、この内訳の 2.7%韓国: 引用元論文 244 件、この内訳の 2.1%
0%23.8%その他 23%

分野

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Immunology and Microbiology2.9%
  • Environmental Science1.5%
  • Engineering1.3%
  • Computer Science0.8%
  • その他2.3%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis19.4%
  • Chronic Obstructive Pulmonary Disease (COPD) Research5.2%
  • Systemic Sclerosis and Related Diseases3.9%
  • Pulmonary Hypertension Research and Treatments3.6%
  • Sarcoidosis and Beryllium Toxicity Research3%
  • Transplantation: Methods and Outcomes2.6%
  • その他62.3%

共著者

全論文

検索で開く
  1. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 4,100

  2. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 3,949

  3. Idiopathic Pulmonary Fibrosis

    著者: , - New England Journal of Medicine 2018 被引用: 2,030

  4. Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa A. Maier, Carlos Matiz, Ferrán Morell, Andrew G. Nicholson, Setu Patolia, Carlos A.C. Pereira, Elisabetta Renzoni, Margaret L. Salisbury, Moisés Selman, Simon Walsh, Wim Wuyts, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 1,012

  5. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 1,444

  6. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , - The Lancet Respiratory Medicine 2019 被引用: 630

  7. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2019 被引用: 286

  8. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore J. Iwashyna, Gísli Jenkins, Martin Kolb, Guy B. Marks, Peter J. Mazzone, J. Randall Moorman, Thomas M. Murphy, Terry L. Noah, Paul N. Reynolds, Dieter Riemann, Richard Russell, Aziz Sheikh, Giovanni Sotgiu, Erik R. Swenson, Rhonda D. Szczesniak, Ronald Szymusiak, Jean–Louis Teboul, Jean‐Louis Vincent - Annals of the American Thoracic Society 2018 被引用: 722

  9. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 267

  10. Generation and persistence of human tissue-resident memory T cells in lung transplantation

    著者: , , , , , , , , , , , , , , , , , , , - Science Immunology 2019 被引用: 294

  11. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

    著者: , , , , , , , , , , , , , , , , - European Respiratory Journal 2015 被引用: 463

  12. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 被引用: 280

  13. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

    著者: , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2014 被引用: 1,330

  14. Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function

    著者: , , , , , , , , , , , , , , , , , , , - JAMA 2019 被引用: 396

  15. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 被引用: 341

  16. Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2013 被引用: 543

  17. Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells

    著者: , , , , , , , - Cell Reports 2019 被引用: 240

  18. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 301

  19. Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading

    著者: , , , , , , , , , , , - Circulation 2011 被引用: 471

  20. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

    著者: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 被引用: 332

  21. Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort Study

    著者: , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 被引用: 308

  22. Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan R Smyth, Iain Stewart, Paul W. Stewart, Erik R. Swenson, Ronald Szymusiak, Jean–Louis Teboul, Jean‐Louis Vincent, Jadwiga A. Wedzicha, David M. Maslove - Critical Care Medicine 2020 被引用: 284

  23. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Puppo, Sara Tomassetti, Valentina Luzzi, Nurdan Köktürk, Nesrin Moğulkoç, Christine Fiddler, Nikhil Hirani, Gísli Jenkins, Toby M. Maher, Philip L. Molyneaux, Helen Parfrey, Rebecca Braybrooke, Timothy S. Blackwell, Peter Jackson, Steven D. Nathan, Mary K. Porteous, Kevin K. Brown, Jason D. Christie, Harold R. Collard, Oliver Eickelberg, Elena Foster, Kevin F. Gibson, Marilyn K. Glassberg, Daniel J. Kass, Jonathan A. Kropski, David J. Lederer, A. Linderholm, Jim Loyd, Susan Mathai, Sydney B. Montesi, Imre Noth, Justin M. Oldham, Amy Palmisciano, Cristina Reichner, Mauricio Rojas, Jesse Roman, Neil W. Schluger, Barry S. Shea, Jeffrey J. Swigris, Paul J. Wolters, Yingze Zhang, Cecilia M. Prêle, Juan Ignacio Enghelmayer, María Otaola, Christopher J. Ryerson, Mauricio Salinas, Martina Šterclová, Tewodros Haile Gebremariam, Marjukka Myllärniemi, Roberto G. Carbone, Haruhiko Furusawa, Masaki Hirose, Yoshikazu Inoue, Yasunari Miyazaki, Ken Ohta, Shin Ohta, Tsukasa Okamoto, Dong Soon Kim, Annie Pardo, Moisés Selman, Alvaro U. Aranda, Moo Suk Park, Jong Sun Park, Jin Woo Song, María Molina‐Molina, Lurdes Planas‐Cerezales, Gunilla Westergren‐Thorsson, Albert V. Smith, Ani Manichaikul, John S. Kim ほか 15 名 - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 80

  24. IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maarten van den Berge - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 35